Cysteamine Therapy for Major Depressive Disorder

Summary

The purpose of this study is to determine whether cysteamine bitartrate, an FDA-approved drug for a non-psychiatric condition, is safe and effective for the treatment of major depression.

Timeline

Start

2008-07

Primary completion

2009-05

Completion

2009-05

Outcome

Outcome not reported

Stopped: “Change in resources available for study procedures.”

Drugs

Indications